Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06128044
Title CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AMpLify)
Acronym AMpLify
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Caribou Biosciences, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Alabama at Birmingham (UAB) RECRUITING Birmingham Alabama 35249-0001 United States Details
Colorado Blood Cancer Institute RECRUITING Denver Colorado 80218 United States Details
The Blood & Marrow Transplant Group of Georgia (BMTGA) RECRUITING Atlanta Georgia 30342 United States Details
Memorial Sloan Kettering Cancer Center (MSKCC) RECRUITING New York New York 10065 United States Details
TriStar Bone Marrow Transplant, LLC RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Fred Hutchinson Cancer Center RECRUITING Seattle Washington 98109-1023 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field